Remedee Labs endorphin stimulator gets US FDA breakthrough device designation for management of fibromyalgia
By, Admin1 min read
Share
The French startup Remedee Labs announced that the FDA has granted Breakthrough Device Designation to its endorphin stimulator for fibromyalgia patients. The FDA
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
